Literature DB >> 2091925

Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

U Wendel1, K Ullrich, H Schmidt, U Batzler.   

Abstract

The daily Phe intakes of normally growing 1- to 6-year-old treated PKU patients were evaluated. The children received protein in amounts that varied from 2.26 +/- 0.47 g/kg body weight per day (mean +/- SD) at the age of 6 to 1.81 +/- 0.35 at the age of 72 months. Mean Phe intakes declining from 34 +/- 7 at the age of 6 months to 15 +/- 5 mg/kg body weight per day at the age of 72 months were required to maintain mean median plasma Phe levels around 6.0 mg/dl.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091925     DOI: 10.1007/BF02126293

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age--Part 1.

Authors:  E Mönch; J Kneer; C Jakobs; M Arnold; H Diehl; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Physical growth in phenylketonuria: II. Growth of treated children in the PKU collaborative study from birth to 4 years of age.

Authors:  V A Holm; R A Kronmal; M Williamson; A F Roche
Journal:  Pediatrics       Date:  1979-05       Impact factor: 7.124

3.  The diagnosis of phenylketonuria: a report from the Collaborative Study of Children Treated for Phenylketonuria.

Authors:  M E O'Flynn; N A Holtzman; M Blaskovics; C Azen; M L Williamson
Journal:  Am J Dis Child       Date:  1980-08

4.  Is phenylalanine requirement in infants and children related to protein intake?

Authors:  E Kindt; K Motzfeldt; S Halvorsen; S O Lie
Journal:  Br J Nutr       Date:  1984-05       Impact factor: 3.718

5.  Phenylalanine intakes of 1- to 6-year-old children with phenylketonuria undergoing therapy.

Authors:  P B Acosta; C Trahms; N S Wellman; M Williamson
Journal:  Am J Clin Nutr       Date:  1983-11       Impact factor: 7.045

6.  Protein requirements in infants and children: a longitudinal study of children treated for phenylketonuria.

Authors:  E Kindt; K Motzfeldt; S Halvorsen; S O Lie
Journal:  Am J Clin Nutr       Date:  1983-05       Impact factor: 7.045

7.  [Differential diagnosis of increased phenylalanine blood level in infancy. Results of the German collaborative study on phenylketonuria (PKU)/hyperphenylalaninemia (HPA)].

Authors:  H Schmidt; P Lutz; U Batzler
Journal:  Monatsschr Kinderheilkd       Date:  1989-02       Impact factor: 0.323

  7 in total
  7 in total

1.  Study design and description of patients.

Authors:  P Lutz; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Preliminary neuropsychological test results.

Authors:  L M de Sonneville; E Schmidt; U Michel; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

3.  Results of psychological testing of patients aged 3-6 years.

Authors:  U Michel; E Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

4.  Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria.

Authors:  Krista S Viau; Heidi J Wengreen; Sharon L Ernst; Nancy L Cantor; Larissa V Furtado; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

5.  Recommendations for protein and amino acid intake in phenylketonuric patients.

Authors:  F Cockburn; B J Clark
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study.

Authors:  A M Paans; J Pruim; G P Smit; G Visser; A T Willemsen; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

7.  Psychological and social findings in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; E Schmidt; P Burgard; K Ullrich
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.